This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Leland Stanford Junior University, The University of British Columbia, University of California. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,512 
2 out of 962 
2 out of 16,025 
Years Active: 2013-2015
Title: Catherine D Van Raamsdonk: Innovator in Melanoma Research
Introduction
Catherine D Van Raamsdonk is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of melanoma research, particularly in understanding genetic mutations associated with this type of cancer. With a total of 2 patents, her work has the potential to impact diagnostic and therapeutic approaches in oncology.
Latest Patents
Her latest patents include groundbreaking methods for detecting mutations in the GNA11 gene in melanocytic neoplasms. This invention provides essential diagnostic and prognostic tools for clinicians. Additionally, she has developed methods for treating melanocytic neoplasms by modulating the activity of the mutated GNA11 gene. Another significant patent focuses on the Gnaq gene, offering similar diagnostic and treatment methodologies for melanocytic neoplasms.
Career Highlights
Catherine has worked with esteemed institutions such as the University of California and Leland Stanford Junior University. Her research has been pivotal in advancing the understanding of melanoma genetics and treatment options.
Collaborations
Catherine has collaborated with notable professionals in her field, including Boris C Bastian and Gregory S Barsh. These partnerships have further enriched her research and contributed to her innovative work.
Conclusion
Catherine D Van Raamsdonk stands out as a leading inventor in melanoma research, with her patents paving the way for improved diagnostic and treatment strategies. Her contributions are invaluable to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile